Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Information on EC 3.1.3.86 - phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase and Organism(s) Homo sapiens and UniProt Accession O15357

for references in articles please use BRENDA:EC3.1.3.86

Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
IUBMB Comments

This enzyme hydrolyses 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) to produce PtdIns(3,4)P2, thereby negatively regulating the PI3K (phosphoinositide 3-kinase) pathways. The enzyme also shows activity toward (PtdIns(1,3,4,5)P4) . The enzyme is involved in several signal transduction pathways in the immune system leading to an adverse range of effects.

The taxonomic range for the selected organisms is: Homo sapiens
The enzyme appears in selected viruses and cellular organisms

Synonyms
ship-1, ship-2, inpp5d, inppl1, 5'-inositol phosphatase, sh2-containing inositol phosphatase, sh2 domain-containing inositol 5-phosphatase, ptdins(3,4,5)p3 5-phosphatase, phosphatidylinositol 5-phosphatase, pi 5-phosphatase, more

SYNONYM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
5'-inositol phosphatase
-
phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase
-
phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2
-
Phosphoinositide 5-phosphatase
-
PI 5-phosphatase
-
PI(3,4,5)P3 5-phosphatase
-
SH2-containing inositol 5-phosphatase 2
-
SH2-containing-inositol-5-phosphatase 2
-
SH2-domain-containing 5 inositol phosphatase
-
SHIP-2
isoform
SHIP2
SHIP2 Ptase
-
Src homology 2 containing inositol 5-phosphatase 2
-
Src homology 2 domain-containing inositol phosphate phosphatase 2
-
Src homology 2-containing inositol phosphatase 1
-
Src homology containing inositol polyphosphate 5-phosphatase-2
-
150-kD IP5Pase
-
-
75 kDa 5-phosphatase
-
-
75 kDa inositol polyphosphate 5-phosphatase, membrane-associated
-
-
inositol polyphosphate 5-phosphatase
-
p150SHIP
-
-
phosphatidylinositol (3,4,5)-trisphosphate 5-phosphatase
-
-
phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase
phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1
-
phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1
-
-
PtdIns(3,4,5)-P3 phosphatase
-
-
PtdIns(3,4,5)P3 5-phosphatase
-
-
PtdIns(3,4,5)P3 phosphatase
-
-
SH2 domain containing 5-phosphatase
-
-
SH2 domain containing inositol 5-phosphatase
-
-
SH2 domain containing inositol 5-phosphatase 2
-
-
SH2 domain-containing inositol 5-phosphatase
-
-
SH2 domain-containing inositol polyphosphate 5-phosphatase 2
-
-
SH2-containing inositol phosphatase
-
-
SHIP-1
SHIP1
Src homology 2 domain containing inositol 5-phosphatase
-
-
Src homology 2 domain-containing inositol 5-phosphatase 1
-
Src homology 2 domain-containing inositol polyphosphate 5-phosphatase 2
-
-
PATHWAY SOURCE
PATHWAYS
MetaCyc
3-phosphoinositide degradation
SYSTEMATIC NAME
IUBMB Comments
1-phosphatidyl-1D-myo-inositol-3,4,5-trisphosphate 5-phosphohydrolase
This enzyme hydrolyses 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) to produce PtdIns(3,4)P2, thereby negatively regulating the PI3K (phosphoinositide 3-kinase) pathways. The enzyme also shows activity toward (PtdIns(1,3,4,5)P4) [5]. The enzyme is involved in several signal transduction pathways in the immune system leading to an adverse range of effects.
SUBSTRATE
PRODUCT
REACTION DIAGRAM
ORGANISM
UNIPROT
LITERATURE
COMMENTARY hide
Reversibility
r=reversible
ir=irreversible
?=not specified
1-phosphatidyl-1D-myo-inositol 1,3,4,5-tetrakisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 1,3,4-trisphosphate + phosphate
show the reaction diagram
Substrates: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
show the reaction diagram
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 4-phosphate + phosphate
show the reaction diagram
Substrates: -
Products: -
?
1D-myo-inositol 1,3,4,5-tetrakisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 1,3,4-trisphosphate + phosphate
show the reaction diagram
Substrates: -
Products: -
?
inositol 1,3,4,5-tetrakisphosphate + H2O
?
show the reaction diagram
Substrates: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 1,3,4,5-tetrakisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 1,3,4-trisphosphate + phosphate
show the reaction diagram
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
show the reaction diagram
1D-myo-inositol 1,3,4,5-tetrakisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 1,3,4-trisphosphate + phosphate
show the reaction diagram
-
Substrates: -
Products: -
?
inositol 1,3,4,5-tetrakisphosphate + H2O
?
show the reaction diagram
-
Substrates: in vitro substrate of SHIP2
Products: -
?
additional information
?
-
NATURAL SUBSTRATE
NATURAL PRODUCT
REACTION DIAGRAM
ORGANISM
UNIPROT
LITERATURE
COMMENTARY hide
REVERSIBILITY
r=reversible
ir=irreversible
?=not specified
1-phosphatidyl-1D-myo-inositol 1,3,4,5-tetrakisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 1,3,4-trisphosphate + phosphate
show the reaction diagram
Substrates: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
show the reaction diagram
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 4-phosphate + phosphate
show the reaction diagram
Substrates: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 1,3,4,5-tetrakisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 1,3,4-trisphosphate + phosphate
show the reaction diagram
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
show the reaction diagram
additional information
?
-
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
(2R)-2-[(S)-hydroxy(2-phenylbenzo[h]quinolin-4-yl)methyl]piperidin-1-ium
-
(2R)-2-[(S)-[5,7-dichloro-3-adamantyl)naphthalen-1-yl](hydroxy)methyl]piperidin-1-ium
-
1D-myo-inositol 1,3,4,5-tetrakisphosphate
-
2-(1-(2,4-dichlorobenzyl)-2-methyl-5-(methylthio)-1H-indol-3-yl)ethanaminium chloride
-
-
2-(1-(4-Bromobenzyl)-2-methyl-5-(methylthio)-1H-indol-3-yl)ethanaminium chloride
-
-
2-(1-(4-chlorobenzyl)-2-methyl-5-(methylthio)-1H-indol-3-yl)ethanaminium chloride
-
-
2-(1-benzyl-2-methyl-1H-indol-3-yl) ethanaminium chloride
-
-
2-(1-benzyl-2-methyl-5-(methylthio)-1H-indol-3-yl)ethanaminium chloride
-
-
2-[1-(2,4-dichlorobenzyl)-2-methyl-5-(methylmercapto)-1H-indol-3-yl] ethanaminium chloride
-
2-[1-(2-chlorobenzyl)-2-methyl-5-(methylmercapto)-1H-indol-3-yl] ethanaminium chloride
-
2-[1-[(2,4-dichlorophenyl)methyl]-2-methyl-5-(methylsulfanyl)-1H-indol-3-yl]ethan-1-aminium
40% inhibition at 0.5 mM
2-[1-[(2-chlorophenyl)methyl]-2-methyl-5-(methylsulfanyl)-1H-indol-3-yl]ethan-1-aminium
-
3-[(2,4-dichlorophenyl)methoxy]-N-[(2,6-difluorophenyl)methyl]thiophene-2-carboxamide
AS1938909, competitive inhibitor of SHIP2
3-[(4-chlorophenyl)methoxy]-N-[(1S)-1-phenylethyl]thiophene-2-carboxamide
AS1949490, competitive inhibitor of SHIP2
6,6'-difluoro biphenyl 3,3',4,4'-tetrakisphosphate
-
-
AS1949490
-
benzene 1,2,3,4-tetrayl tetrakis(phosphate)
-
benzene 1,2,3,5-tetrayl tetrakis(phosphate)
-
benzene 1,2,4,5-tetrayl tetrakis(phosphate)
-
biphenyl 2,2',4,4',5,5'-hexakisphosphate
-
-
biphenyl 2,3',4,5',6-pentakisphosphate
-
biphenyl 2,3',4,5',6-pentayl pentakis(phosphate)
-
biphenyl 3,3',4,4',5,5'-hexakisphosphate
-
estramustine phosphate
-
-
galloflavin
-
insulin receptor tyrosine kinase substrate
i.e. IRTKS, i.e. BAI1-associated protein 2-like 1, i.e. BAIAP2L1. Interacts with SHIP2 to suppress its activity
-
N-(4-[[(4-chlorophenyl)methoxy]methyl]pyridin-2-yl)-2-phenylacetamide
-
N-(4-[[(4-chlorophenyl)methoxy]methyl]pyridin-2-yl)-3-phenylpropanamide
-
N-[4-[(4-chlorophenyl)methoxy]pyridin-2-yl]-2-(2,6-difluorophenyl)acetamide
-
N-[4-[(4-chlorophenyl)methoxy]pyridin-2-yl]-2-phenylacetamide
-
N-[4-[(4-chlorophenyl)methoxy]pyridin-2-yl]-3-phenylpropanamide
-
NGD-61338
-
purpurogallin
-
TNO155
inhibitor of isoform SHIP-2
tryptamine K103
-
-
2,3-bisphosphoglycerate
-
-
2-(1-(2,4-dichlorobenzyl)-2-methyl-5-(methylthio)-1H-indol-3-yl)ethanaminium chloride
-
-
2-(1-(4-Bromobenzyl)-2-methyl-5-(methylthio)-1H-indol-3-yl)ethanaminium chloride
-
-
2-(1-(4-chlorobenzyl)-2-methyl-5-(methylthio)-1H-indol-3-yl)ethanaminium chloride
-
-
2-(1-benzyl-2-methyl-1H-indol-3-yl) ethanaminium chloride
-
-
2-(1-benzyl-2-methyl-5-(methylthio)-1H-indol-3-yl)ethanaminium chloride
-
-
3-alpha-aminocholestane
selective inhibitor of isoform SHIP-1
4-hydroxymercuribenzoate
-
-
AQX-1125
Rosiptor, inhibitor of isoform SHIP-1
NSC13480
NSC305787
sodium stibogluconate
inhibitor of isoform SHIP-1
tryptamine K103
-
-
additional information
-
ACTIVATING COMPOUND
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate directly interacts with the pleckstrin homology-related (PHR) domain to trigger allosteric activation
phosphoinositide
phosphoinositide-induced transition to a high activity state of the enzyme increases phosphatase activity up to 10-15fold
phosphoinositide lipid
binding of its pleckstrin homology-related (PHR) domain to specific phosphoinositide lipids in the cell membrane enhances catalytic activity
-
immune receptor-derived tyrosine-phosphorylated peptide
the presence of an immune receptor-derived tyrosine-phosphorylated peptide added in solution or membrane tethered, SHIP1-lipid phosphatase activity is robustly stimulated
-
additional information
-
KM VALUE [mM]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.043 - 0.061
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate
0.125
1D-myo-inositol 1,3,4,5-tetrakisphosphate
pH 7, 23°C
0.082 - 0.126
Inositol 1,3,4,5-tetrakisphosphate
TURNOVER NUMBER [1/s]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.69 - 4.44
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate
4.85
1D-myo-inositol 1,3,4,5-tetrakisphosphate
pH 7, 23°C
1.2 - 1.64
Inositol 1,3,4,5-tetrakisphosphate
Ki VALUE [mM]
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.03
(2R)-2-[(S)-hydroxy(2-phenylbenzo[h]quinolin-4-yl)methyl]piperidin-1-ium
pH and temperature not specified in the publication
0.063
(2R)-2-[(S)-[5,7-dichloro-3-adamantyl)naphthalen-1-yl](hydroxy)methyl]piperidin-1-ium
pH and temperature not specified in the publication
0.5
2-[1-[(2-chlorophenyl)methyl]-2-methyl-5-(methylsulfanyl)-1H-indol-3-yl]ethan-1-aminium
pH and temperature not specified in the publication
0.00057
3-[(2,4-dichlorophenyl)methoxy]-N-[(2,6-difluorophenyl)methyl]thiophene-2-carboxamide
pH and temperature not specified in the publication
0.00062
3-[(4-chlorophenyl)methoxy]-N-[(1S)-1-phenylethyl]thiophene-2-carboxamide
pH and temperature not specified in the publication
IC50 VALUE [mM]
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.03
(2R)-2-[(S)-hydroxy(2-phenylbenzo[h]quinolin-4-yl)methyl]piperidin-1-ium
Homo sapiens
pH and temperature not specified in the publication
0.063
(2R)-2-[(S)-[5,7-dichloro-3-adamantyl)naphthalen-1-yl](hydroxy)methyl]piperidin-1-ium
Homo sapiens
pH and temperature not specified in the publication
0.0023
1D-myo-inositol 1,3,4,5-tetrakisphosphate
Homo sapiens
pH 7.3, 25°C
0.03
2-(1-(2,4-dichlorobenzyl)-2-methyl-5-(methylthio)-1H-indol-3-yl)ethanaminium chloride
Homo sapiens
pH 7.4, 37°C
-
0.058
2-(1-(4-Bromobenzyl)-2-methyl-5-(methylthio)-1H-indol-3-yl)ethanaminium chloride
Homo sapiens
pH 7.4, 37°C
-
0.014
2-(1-(4-chlorobenzyl)-2-methyl-5-(methylthio)-1H-indol-3-yl)ethanaminium chloride
Homo sapiens
pH 7.4, 37°C
-
0.062
2-(1-benzyl-2-methyl-1H-indol-3-yl) ethanaminium chloride
Homo sapiens
pH 7.4, 37°C
-
0.012
2-(1-benzyl-2-methyl-5-(methylthio)-1H-indol-3-yl)ethanaminium chloride
Homo sapiens
pH 7.4, 37°C
-
0.5
2-[1-[(2-chlorophenyl)methyl]-2-methyl-5-(methylsulfanyl)-1H-indol-3-yl]ethan-1-aminium
Homo sapiens
pH and temperature not specified in the publication
0.00057
3-[(2,4-dichlorophenyl)methoxy]-N-[(2,6-difluorophenyl)methyl]thiophene-2-carboxamide
Homo sapiens
pH and temperature not specified in the publication
0.00062
3-[(4-chlorophenyl)methoxy]-N-[(1S)-1-phenylethyl]thiophene-2-carboxamide
Homo sapiens
pH and temperature not specified in the publication
0.000061
6,6'-difluoro biphenyl 3,3',4,4'-tetrakisphosphate
Homo sapiens
pH 7.3, 25°C
-
0.000027
biphenyl 2,2',4,4',5,5'-hexakisphosphate
Homo sapiens
pH 7.3, 25°C
-
0.000029
biphenyl 2,3',4,5',6-pentakisphosphate
Homo sapiens
pH 7.3, 25°C
0.000023
biphenyl 3,3',4,4',5,5'-hexakisphosphate
Homo sapiens
pH 7.3, 25°C
0.0355
estramustine phosphate
Homo sapiens
pH 7.3, 25°C
-
0.0055
purpurogallin
Homo sapiens
pH 7.3, 25°C
0.01
tryptamine K103
Homo sapiens
pH 7.4, 37°C
-
0.03
2-(1-(2,4-dichlorobenzyl)-2-methyl-5-(methylthio)-1H-indol-3-yl)ethanaminium chloride
Homo sapiens
pH 7.4, 37°C
-
0.051
2-(1-(4-Bromobenzyl)-2-methyl-5-(methylthio)-1H-indol-3-yl)ethanaminium chloride
Homo sapiens
pH 7.4, 37°C
-
0.011
2-(1-(4-chlorobenzyl)-2-methyl-5-(methylthio)-1H-indol-3-yl)ethanaminium chloride
Homo sapiens
pH 7.4, 37°C
-
0.055
2-(1-benzyl-2-methyl-1H-indol-3-yl) ethanaminium chloride
Homo sapiens
pH 7.4, 37°C
-
0.013
2-(1-benzyl-2-methyl-5-(methylthio)-1H-indol-3-yl)ethanaminium chloride
Homo sapiens
pH 7.4, 37°C
-
0.005
tryptamine K103
Homo sapiens
pH 7.4, 37°C
-
top print hide Go to Organism Search
ORGANISM
COMMENTARY hide
LITERATURE
UNIPROT
SEQUENCE DB
SOURCE
top print hide Go to Source Tissue Search
SOURCE TISSUE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
SOURCE
top print hide Go to Localization Search
Highest Expressing Human Cell Lines
Cell Line Links Gene Links
GENERAL INFORMATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
drug target
therapeutic target for pathophysiologies dependent on PtdIns(3,4,5)P3 and PtdIns(3,4)P2. The study reveals a potentially druggable allosteric site on the enzyme
malfunction
metabolism
the enzyme has been heavily implicated in serious diseases such as cancer and type 2 diabetes
physiological function
malfunction
enzyme deficiency leads to myeloproliferation and B-cell lymphoma in mice
metabolism
-
the enzyme participates in the insulin signalling pathway in vivo
physiological function
additional information
UNIPROT
ENTRY NAME
ORGANISM
NO. OF AA
NO. OF TRANSM. HELICES
MOLECULAR WEIGHT[Da]
SOURCE
SEQUENCE
LOCALIZATION PREDICTION?
SHIP2_HUMAN
1258
0
138599
Swiss-Prot
-
MOLECULAR WEIGHT
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
155000
isoform SHIP2, gel filtration
30360
gel filtration, truncated protein SHIP2(176-298)
36300
gel filtration, truncated protein SHIP2(118-298)
103000
-
catalytic part of SHIP2, gel filtration
145000
150000
-
gel filtration
155000
isoform SHIP2, gel filtration
160000
-
full-length enzyme, gel filtration
170000
-
phosphorylated protein, gel filtration
75000
-
cytosol-associated 5-phosphatase, gel filtration
SUBUNIT
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
homodimer
SHIP2(118-298) and SHIP2(176-298), two truncated proteins harboring the RhoA-binding domain (RBD)
POSTTRANSLATIONAL MODIFICATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
phosphoprotein
isoforms SHIP2 and SHIP1 are constitutively tyrosine phosphorylated in chronic myelogenous leukemia progenitor cells. Stimulation of human hematopoietic growth factor responsive cell lines with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor leads to rapid tyrosine phosphorylation of SHIP2 and its resulting association with src homologous and collagen gene
phosphoprotein
CRYSTALLIZATION (Commentary)
ORGANISM
UNIPROT
LITERATURE
a fragment of human SHIP2 containing the phosphatase domain and a region proposed to resemble a C2 domain is crystallized by the hanging drop vapor diffusion method, using 0.1 M Bis-Tris propane pH 7.0, 0.2 M NaNO3, 20% (w/v) PEG 3350, 0.025 % (w/v) CH2Cl2, 2 mM Tris(2-carboxyethyl)phosphine
crystals are grown in sitting drops at 16°C
using 100 mM Bis-Tris propane, pH 7.0, 0.2 M NaNO3, 20% (w/v) PEG3350, 0.025% (v/v) CH2Cl2
PROTEIN VARIANTS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
D608A
catalytically inactive
F593D/L597D
the mutations largely mimic the absence of the C2 domain
R649A
the mutation removes C2 domain effects on inositol 1,3,4,5-tetrakisphosphate but not 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate kinetics
additional information
characterization of SHIP1 truncation mutants reveals that both the N-terminal SH2 domain and the disordered C-terminal tail limit SHIP1 phosphatase activity but to different extents
PURIFICATION (Commentary)
ORGANISM
UNIPROT
LITERATURE
GST resin column chromatography, Source 15S column chromatography, and Superdex 200 gel filtration
SHIP2(118-298) and SHIP2(176-298), two truncated proteins harboring the RhoA-binding domain (RBD) are designed, expressed, and purified
glutathione-agarose resin column chromatography
-
Ni2+-agarose column chromatography
-
the enzyme is co-purified with the p85/pll0 form of PI 3-kinase, by Q-Sepharose column chromatography, S-Sepharose column chromatography, hydroxyapatite column chromatography and Mono S column chromatography
-
CLONED (Commentary)
ORGANISM
UNIPROT
LITERATURE
expressed in Escherichia coli Rosetta2(DE3)pLysS cells
expressed in HEK-293 cells
expression in Escherichia coli
expression in Escherichia coli, SHIP2(118-298) and SHIP2(176-298), two truncated proteins harboring the RhoA-binding domain (RBD), exist as homo-dimers in solution by multi-angle light scattering
expressed in COS-7 cells
-
expressed in Escherichia coli BL21(DE3) cells
-
expressed in Escherichia coli DH5alphaF' cells and in COS-7 cells
-
EXPRESSION
ORGANISM
UNIPROT
LITERATURE
enzyme expression is increased in colorectal cancer tissue in comparison to adjacent normal tissue
virusecurinine, a plant alkaloid, downregulates enzyme expression
enzyme activity is not increased after thrombin stimulation of COS-7 cells
-
enzyme activity is stimulated by the macrophage colony-stimulating factor
-
the enzyme is stimulated by 50 ng/ml epidermal growth factor
-
APPLICATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
medicine
-
SHIP-1 is a risk marker for acute ischemic stroke
REF.
AUTHORS
TITLE
JOURNAL
VOL.
PAGES
YEAR
ORGANISM (UNIPROT)
PUBMED ID
SOURCE
Jackson, S.P.; Schoenwaelder, S.M.; Matzaris, M.; Brown, S.; Mitchell, C.A.
Phosphatidylinositol 3,4,5-trisphosphate is a substrate for the 75 kDa inositol polyphosphate 5-phosphatase and a novel 5-phosphatase which forms a complex with the p85/p110 form of phosphoinositide 3-kinase
EMBO J.
14
4490-4500
1995
Homo sapiens
Manually annotated by BRENDA team
Vandeput, F.; Backers, K.; Villeret, V.; Pesesse, X.; Erneux, C.
The influence of anionic lipids on SHIP2 phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase activity
Cell. Signal.
18
2193-2199
2006
Homo sapiens
Manually annotated by BRENDA team
Drayer, A.L.; Pesesse, X.; De Smedt, F.; Woscholski, R.; Parker, P.; Erneux, C.
Cloning and expression of a human placenta inositol 1,3,4,5-tetrakisphosphate and phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase
Biochem. Biophys. Res. Commun.
225
243-249
1996
Homo sapiens
Manually annotated by BRENDA team
Drayer, A.; Pesesse, X.; De Smedt, F.; Communi, D.; Moreau, C.; Erneux, C.
The family of inositol and phosphatidylinositol polyphosphate 5-phosphatases
Biochem. Soc. Trans.
24
1001-1005
1996
Homo sapiens, Rattus norvegicus
Manually annotated by BRENDA team
Wisniewski, D.; Strife, A.; Swendeman, S.; Erdjument-Bromage, H.; Geromanos, S.; Kavanaugh, W.M.; Tempst, P.; Clarkson, B.
A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells
Blood
93
2707-2720
1999
Homo sapiens (Q92835), Homo sapiens (O15357)
Manually annotated by BRENDA team
Zwaenepoel, K.; Goris, J.; Erneux, C.; Parker, P.J.; Janssens, V.
Protein phosphatase 2A PR130/Balpha1 subunit binds to the SH2 domain-containing inositol polyphosphate 5-phosphatase 2 and prevents epidermal growth factor (EGF)-induced EGF receptor degradation sustaining EGF-mediated signaling
FASEB J.
24
538-547
2010
Homo sapiens
Manually annotated by BRENDA team
Pesesse, X.; Moreau, C.; Drayer, A.L.; Woscholski, R.; Parker, P.; Erneux, C.
The SH2 domain containing inositol 5-phosphatase SHIP2 displays phosphatidylinositol 3,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate 5-phosphatase activity
FEBS Lett.
437
301-303
1998
Homo sapiens
Manually annotated by BRENDA team
Lioubin, M.N.; Algate, P.A.; Tsai, S.; Carlberg, K.; Aebersold, A.; Rohrschneider, L.R.
p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity
Genes Dev.
10
1084-95
1996
Homo sapiens
Manually annotated by BRENDA team
Giuriato, S.; Payrastre, B.; Drayer, A.L.; Plantavid, M.; Woscholski, R.; Parker, P.; Erneux, C.; Chap, H.
Tyrosine phosphorylation and relocation of SHIP are integrin-mediated in thrombin-stimulated human blood platelets
J. Biol. Chem.
272
26857-26863
1997
Homo sapiens
Manually annotated by BRENDA team
Pesesse, X.; Dewaste, V.; De Smedt, F.; Laffargue, M.; Giuriato, S.; Moreau, C.; Payrastre, B.; Erneux, C.
The Src homology 2 domain containing inositol 5-phosphatase SHIP2 is recruited to the epidermal growth factor (EGF) receptor and dephosphorylates phosphatidylinositol 3,4,5-trisphosphate in EGF-stimulated COS-7 cells
J. Biol. Chem.
276
28348-28355
2001
Homo sapiens
Manually annotated by BRENDA team
Tu, W.J.; Liu, X.Y.; Dong, H.; Yu, Y.; Wang, Y.; Chen, H.
Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1: a meaningful and independent marker to predict stroke in the Chinese population
J. Mol. Neurosci.
52
507-514
2014
Homo sapiens
Manually annotated by BRENDA team
Ramos, A.R.; Elong Edimo, W.; Erneux, C.
Phosphoinositide 5-phosphatase activities control cell motility in glioblastoma Two phosphoinositides PI(4,5)P2 and PI(3,4)P2 are involved
Adv. Biol. Regul.
67
40-48
2018
Homo sapiens (O15357)
Manually annotated by BRENDA team
Gorgani-Firuzjaee, S.; Adeli, K.; Meshkani, R.
Inhibition of SH2-domain-containing inositol 5-phosphatase (SHIP2) ameliorates palmitate induced-apoptosis through regulating Akt/FOXO1 pathway and ROS production in HepG2 cells
Biochem. Biophys. Res. Commun.
464
441-446
2015
Homo sapiens (O15357)
Manually annotated by BRENDA team
Eramo, M.J.; Mitchell, C.A.
Regulation of PtdIns(3,4,5)P3/Akt signalling by inositol polyphosphate 5-phosphatases
Biochem. Soc. Trans.
44
240-252
2016
Homo sapiens (Q92835), Homo sapiens (O15357)
Manually annotated by BRENDA team
Russo, C.M.; Adhikari, A.A.; Wallach, D.R.; Fernandes, S.; Balch, A.N.; Kerr, W.G.; Chisholm, J.D.
Synthesis and initial evaluation of quinoline-based inhibitors of the SH2-containing inositol 5-phosphatase (SHIP)
Bioorg. Med. Chem. Lett.
25
5344-5348
2015
Homo sapiens (Q92835)
Manually annotated by BRENDA team
Thomas, M.P.; Erneux, C.; Potter, B.V.
SHIP2 structure, function and inhibition
ChemBioChem
18
233-247
2017
Homo sapiens (O15357)
Manually annotated by BRENDA team
Le Coq, J.; Camacho-Artacho, M.; Velazquez, J.V.; Santiveri, C.M.; Gallego, L.H.; Campos-Olivas, R.; Doelker, N.; Lietha, D.
Structural basis for interdomain communication in SHIP2 providing high phosphatase activity
eLife
6
e26640
2017
Homo sapiens (O15357)
Manually annotated by BRENDA team
Gorgani-Firuzjaee, S.; Meshkani, R.
SH2 domain-containing inositol 5-phosphatase (SHIP2) inhibition ameliorates high glucose-induced de-novo lipogenesis and VLDL production through regulating AMPK/mTOR/SREBP1 pathway and ROS production in HepG2 cells
Free Radic. Biol. Med.
89
679-689
2015
Homo sapiens (O15357)
Manually annotated by BRENDA team
Rajadurai, C.V.; Havrylov, S.; Coelho, P.P.; Ratcliffe, C.D.; Zaoui, K.; Huang, B.H.; Monast, A.; Chughtai, N.; Sangwan, V.; Gertler, F.B.; Siegel, P.M.; Park, M.
5-Inositol phosphatase SHIP2 recruits Mena to stabilize invadopodia for cancer cell invasion
J. Cell Biol.
214
719-734
2016
Homo sapiens (O15357)
Manually annotated by BRENDA team
Elong Edimo, W.; Ghosh, S.; Derua, R.; Janssens, V.; Waelkens, E.; Vanderwinden, J.M.; Robe, P.; Erneux, C.
SHIP2 controls plasma membrane PI(4,5)P2 thereby participating in the control of cell migration in 1321 N1 glioblastoma cells
J. Cell Sci.
129
1101-1114
2016
Homo sapiens (O15357)
Manually annotated by BRENDA team
Ghosh, S.; Scozzaro, S.; Ramos, A.R.; Delcambre, S.; Chevalier, C.; Krejci, P.; Erneux, C.
Inhibition of SHIP2 activity inhibits cell migration and could prevent metastasis in breast cancer cells
J. Cell Sci.
131
jcs216408
2018
Homo sapiens (O15357)
Manually annotated by BRENDA team
Dempke, W.C.M.; Uciechowski, P.; Fenchel, K.; Chevassut, T.
Targeting SHP-1, 2 and SHIP pathways a novel strategy for cancer treatment?
Oncology
95
257-269
2018
Homo sapiens (Q92835), Homo sapiens (O15357)
Manually annotated by BRENDA team
Hoekstra, E.; Das, A.M.; Willemsen, M.; Swets, M.; Kuppen, P.J.; van der Woude, C.J.; Bruno, M.J.; Shah, J.P.; Ten Hagen, T.L.; Chisholm, J.D.; Kerr, W.G.; Peppelenbosch, M.P.; Fuhler, G.M.
Lipid phosphatase SHIP2 functions as oncogene in colorectal cancer by regulating PKB activation
Oncotarget
7
73525-73540
2016
Homo sapiens (O15357)
Manually annotated by BRENDA team
Le Coq, J.; Heredia Gallego, L.; Lietha, D.
Expression, purification, crystallisation and X-ray crystallographic analysis of a truncated form of human Src homology 2 containing inositol 5-phosphatase 2
Protein J.
35
225-230
2016
Homo sapiens (O15357)
Manually annotated by BRENDA team
Le Coq, J.; Lopez Navajas, P.; Rodrigo Martin, B.; Alfonso, C.; Lietha, D.
A new layer of phosphoinositide-mediated allosteric regulation uncovered for SHIP2
FASEB J.
35
e21815
2021
Homo sapiens (O15357)
Manually annotated by BRENDA team
Wu, C.; Cui, X.; Huang, L.; Shang, X.; Wu, B.; Wang, N.; He, K.; Han, Z.
Irtks promotes insulin signaling transduction through inhibiting ship2 phosphatase activity
Int. J. Mol. Sci.
20
2834
2019
Homo sapiens (O15357)
Manually annotated by BRENDA team
Waddell, G.L.; Drew, E.E.; Rupp, H.P.; Hansen, S.D.
Mechanisms controlling membrane recruitment and activation of the autoinhibited SHIP1 inositol 5-phosphatase
J. Biol. Chem.
299
105022
2023
Homo sapiens (Q92835)
Manually annotated by BRENDA team
Whitfield, H.; Hemmings, A.M.; Mills, S.J.; Baker, K.; White, G.; Rushworth, S.; Riley, A.M.; Potter, B.V.L.; Brearley, C.A.
Allosteric site on SHIP2 identified through fluorescent ligand screening and crystallography a potential new target for intervention
J. Med. Chem.
64
3813-3826
2021
Homo sapiens (O15357)
Manually annotated by BRENDA team
Fernandes, S.; Meyer, S.T.; Shah, J.P.; Adhikari, A.A.; Kerr, W.G.; Chisholm, J.D.
N1-Benzyl tryptamine Pan-SHIP1/2 inhibitors synthesis and preliminary biological evaluation as anti-tumor agents
Molecules
27
8451
2022
Homo sapiens (Q92835), Homo sapiens (O15357)
Manually annotated by BRENDA team
Zhou, H.; Yue, X.; Wang, Z.; Li, S.; Zhu, J.; Yang, Y.; Liu, M.
Expression, purification and characterization of the RhoA-binding domain of human SHIP2 in E. coli
Protein Expr. Purif.
180
105821
2021
Homo sapiens (O15357)
Manually annotated by BRENDA team